Pitfalls in the diagnosis of carcinoid in patients treated with aminosalicylates;Úskalí v diagnostice karcinoidu u pacientů léčených aminosalicyláty

Vnitrni Lekarstvi

Volumn 49, Issue 3, 2003, Pages 200-204

  Dastych Jr , M ^a   Dastych Sr , M ^b   Zboril V ^a   Senkyrrik M ^a   Stary K ^a   Caslavsky J ^c   Chmelik J ^c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b Oddeleni Klinicke Biochemie   (Czech Republic)

^c Ceske Virtualni Aerolinie   (Czech Republic)

Author keywords

Assessment of 5 hydroxyindole acetic acid in urine; Carcinoid; Crohn's disease; Treatment with aminosalicylates

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ACETYLSALICYLIC ACID; BUFFER; SEROTONIN; AMINOSALICYLIC ACID DERIVATIVE; TUMOR MARKER;

ANALYTIC METHOD; ARTICLE; CARCINOID; CHRONIC DISEASE; CLINICAL ARTICLE; CROHN DISEASE; DESORPTION; DIAGNOSTIC ERROR; DRUG EXCRETION; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IONIZATION; LABORATORY TEST; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL ASSESSMENT; METABOLITE; PH; SCREENING TEST; TREATMENT WITHDRAWAL; URINARY EXCRETION; ADULT; FEMALE; GASTROINTESTINAL TUMOR; LABORATORY DIAGNOSIS; MALE; URINE;

ADULT; AMINOSALICYLIC ACIDS; CARCINOID TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROHN DISEASE; FALSE POSITIVE REACTIONS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037642098     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Edwin, B. A., Jerome, M., Feldman, M. D. et al.: Ileal carcinoid tumors simulating Crohn's disease: incidence among 176 consecutive cases of ileal carcinoid. Am. J. Gastroenterol., 92 (11), 1997, 2062-2065
2. El-Salhy, M., Danielsson, A., Stenling, R. et al.: Colonic endocrine cells in inflammatory bowel disease. J. Int. Med., 242, 1997, 413-419
3. Gershon, M. D.: Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment. Pharmacol. Ther., 13 (2), 1999, 15-30
4. Sanger, G. J.: 5-Hydroxytryptamine and functional bowel disorders. Neurogastroenterol. Mot., 8, 1996, 319-331
5. th edition Harrison's Principles of Internal Medicine, 585-591, International edition, 1998
6. William, F., Stenson, M. D.: Small intestine. Gastroenterol., 16, 2000, 99-101 2000
7. El Salhy, M., Norrgard, O., Spinell, S.: Abnormal colonic endocrine cells in patients with chronic idiopathic slow transit constipation. Scand. J. Gastroenterol., 10, 1999, 1007-1011
8. Ireland, A., Priddle, J. D., Jewel, D. P.: Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid. Scand. J. Gastroenterol., 23, suppl 148, 1988, 53
9. Stephen Hanauer, M. et al.: Long-term management of Crohn's disease with Mesalamine capsules (Pentasa). Am. J. Gastroenterol., 88 (9), 1993, 1343-1351
10. Stephen Hanauer, M. et al.: Mesalamine capsules for treatment of active ulcerative colitis: results of controlled trial. Am. J. Gastroenterol., 88 (8), 1993, 1188-1197
11. Magro, F. et al.: Impaired synthesis or cellular storage of norepinephrine, dopamine and 5-hydroxytryptamine in human inflammatory bowel disease. Dig. Dis. Sci., 47 (1), 2002, 216-224
12. Belai, A., Boulos, P. B., Robson, T. et al.: Neurochemical coding on the small intestine of patients with Crohn's disease. Gut, 40 (6), 1997, 767-774
13. Abu-Qurshin, R. et al.: Crohn's disease associated with pellagra and increased excretion of 5-hydroxyindolacetic acid. Am. J. Med. Sci., 313 (2), 1997, 111-113
14. Coward, S., Boa, F. G., Sherwood, R. A.: Sulfasalazine interference with HPLC assay of 5-hydroxyintole-3-acetic acid. Clin. Chem., 41 (5), 1995, 765-766
15. Walker, P. L. et al.: Interference by naproxen in the urinary 5-hydroxyindolacetic acid assay is due to a metabolite, desmethylnaproxen. Ann. Clin. Biochem, 24 (3), 1987, 177-181
16. Deacon, A. C., Bartlett, W. A.: Interferference by acetic acid in urinary 5-hydroxyindoleacetic acid determintaion. Clin. Chem, 28 (1), 1982, 250-251
17. Clark, P. M., Kricka, L. J.: Interference by diazepam in the determination of 5-hydroxyindol-3-acetic acid. Ann. Clin. Biochem. 14 (4), 1977, 233-234
18. Ahlberg, C. D.: Interference in the fluorometric quantitation of urinary 5-hydroxyindolacetic acid by aspirin. Biochem. Pharmacol., 20 (2), 1971, 497-500
19. Bednář, B. et al.: Patologie, Avicenum 1984
20. Tamossetti, P. et al.: Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann. Oncol. 12 (2), 2001, 95-99
21. Mařatka, Z. et al.: Gastroenterologie, Nakladatelství Karolinum 1999
22. Silbernagl, S., Despopoulos, A.: Atlas fysiologie člověka, Avicenum, 1993
23. Seregni E. et al.: Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann. Oncol., 12 (2), 2001, 69-72
24. Westberg, G. et al.: Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome. Br. J. Surg., 88 (6), 2001, 865-872
25. Eriksson, B. et al.: Tumor markers in neuroendocrine tumours. Digestion., 62 (1), 2000, 33-38